Skip to main content
Veterinary Medicines

Pana Veyxal Salbe masť

Authorised
  • Retinol palmitate
  • ALPHATOCOPHEROL ACETATE
  • Chymotrypsin
  • Trypsin
  • Papain

Podatki o zdravilu

Učinkovina / Jakost:
  • Na voljo samo v English
    4250.00
    international unit(s)
    /
    1.00
    gram(s)
  • Na voljo samo v English
    2.50
    milligram(s)
    /
    1.00
    gram(s)
  • Na voljo samo v English
    52.00
    FIP
    /
    1.00
    gram(s)
  • Na voljo samo v English
    26.00
    FIP
    /
    1.00
    gram(s)
  • Na voljo samo v English
    2.80
    FIP
    /
    1.00
    gram(s)
Farmacevtska oblika:
  • Mazilo
Withdrawal period by route of administration:
  • Cutaneous use
    • govedo
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Horse
    • Pig
      • Meat and offal
        0
        day
    • Sheep
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Goat
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Dog
    • Cat
Anatomsko-terapevtsko-kemična veterinarska oznaka (ATCvet):
  • QD11AX
Status dovoljenja:
  • Valid
Authorised in:
  • Slovakia
Opis ovojnine:

Dodatne informacije

Entitlement type:
Imetnik dovoljenja za promet z zdravilom:
  • Veyx Pharma GmbH
Marketing authorisation date:
Proizvodna mesta, odgovorna za sproščanje serij:
  • Veyx Pharma GmbH
Pristojni organ:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Številka dovoljenja :
  • 96/158/94-S
Datum spremembe statusa dovoljenja:

Dokumenti

Combined File of all Documents

Ta dokument ne obstaja v tem jeziku (slovenščina). Spodaj ga najdete v drugem jeziku.
Slovak (PDF)
Objavljeno na: 18/01/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."